The effects of A-ring and D-ring metabolites of estradiol on the proliferation of vascular endothelial cells.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Life Science

• Publication date

  2000-08-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0024-3205(00)00747-5PMID 10983858
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [The significance of estrogen metabolism for hormone-dependent neoplasms from the clinical-pharmacological viewpoint].

  1999cited by this paper
• Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells.

  1998cited by this paper
• Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.

  1998cited by this paper
• Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol

  1997cited by this paper
• Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function.

  1996cited by this paper
• Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.

  1995cited by this paper
• Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model.

  1995cited by this paper
• The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

  1994cited by this paper
• Evidence for soluble and nuclear site I binding of estrogens in human aorta.

  1993cited by this paper
• The O-methylation of 4-hydroxyestradiol is inhibited by 2-hydroxyestradiol: implications for estrogen-induced carcinogenesis.

  1990cited by this paper
• Quantification of cells cultured on 96-well plates.

  1989cited by this paper
• Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology.

  1980cited by this paper

• Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems

  2020cites this paper
• Markers of Local and Systemic Estrogen Metabolism in Endometriosis

  2020cites this paper
• 2-Methoxyestradiol in Pulmonary Arterial Hypertension: A New Disease Modifier

  2019cites this paper
• Sensitivity of the LuminoTox tool to monitor contaminants of emerging concern in municipal secondary wastewater effluent.

  2017cites this paper
• MODERN CONCEPTS OF ESTROGENS ROLE AT PREGNANCY (REVIEW)

  2016cites this paper
• -estradiol in endothelial cells β three genes by 17 Time- and dose-dependent differential upregulation of

  2015cites this paper
• Biomarkers of Preeclampsia 2-Methoxyestradiol Plasma Levels Are Associated With Clinical Severity Indices and

  2015cites this paper
• Aberrant Synthesis, Metabolism, and Plasma Accumulation of Circulating Estrogens and Estrogen Metabolites in Preeclampsia Implications for Vascular Dysfunction

  2013cites this paper
• Estradiol Synthesis and Metabolism and Risk of Ovarian Cancer in Older Women Taking Prescribed or Plant-derived Estrogen Supplementation

  2013cites this paper
• Electron emission and product analysis of estrone: progesterone interactions studied by experiments in vitro

  2011cites this paper
• Injectable delivery system of 2-methoxyestradiol for breast cancer therapy using biodegradable thermosensitive poly(organophosphazene) hydrogel

  2011influential citation
• Estradiol-17&bgr; and Its Cytochrome P450- and Catechol-O-Methyltransferase–Derived Metabolites Stimulate Proliferation in Uterine Artery Endothelial Cells: Role of Estrogen Receptor-&agr; Versus Estrogen Receptor-&bgr;

  2010cites this paper
• Estrogens and Development of Pulmonary Hypertension: Interaction of Estradiol Metabolism and Pulmonary Vascular Disease

  2010influential citation
• The 4-hydroxyestrone: Electron emission, formation of secondary metabolites and mechanisms of carcinogenesis.

  2010cites this paper
• Estradiol Metabolites and their Possible Role in Gynaecological Cancer

  2010cites this paper
• Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

  2010cites this paper
• Are estradiol metabolites involved in gynaecological carcinogenesis?

  2010cites this paper
• Metabolite formation of 17alpha-hydroxyprogesterone as a consequence of e⁻(aq)-emission and progesterone effect regarding cancer.

  2010cites this paper
• 2-Ethoxyestradiol is antimitogenic and attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling.

  2008cites this paper
• Vascular Actions of Estrogens: Functional Implications

  2008cites this paper
• EXOGENOUS ESTROGEN RAPIDLY ATTENUATES PULMONARY ARTERY VASOREACTIVITY AND ACUTE HYPOXIC PULMONARY VASOCONSTRICTION

  2008cites this paper
• Breast cancer: are oestrogen metabolites carcinogenic?

  2007cites this paper
• Raloxifene increases proliferation of human endothelial cells in association with increased gene expression of cyclins A and B1.

  2007cites this paper
• The complex role of estrogens in inflammation.

  2007cites this paper
• Different effects of estradiol and various antiestrogens on TNF-alpha-induced changes of biochemical markers for growth and invasion of human breast cancer cells.

  2006cites this paper
• Wirkungen von Estradiol, Tamoxifen und 2-Methoxyestradiol auf TNF-alpha-induzierte Veränderungen von Markern für Tumorwachstum und Tumorinvasion von Brustkrebszellen

  2006cites this paper
• Östradiolmetabolismus und gynäkologische Malignome

  2005cites this paper
• New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.

  2005cites this paper
• Estradiol Metabolites Attenuate Monocrotaline-Induced Pulmonary Hypertension in Rats

  2005cites this paper
• Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations.

  2004cites this paper
• Inhibition of Human Breast Cancer Cell Proliferation with Estradiol Metabolites is as Effective as with Tamoxifen

  2004cites this paper
• Chemotherapy of breast cancer-additive anticancerogenic effects by 2-methoxyestradiol?

  2004cites this paper
• Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy.

  2004cites this paper
• Breast cancer risk during HRT: influence of estradiol metabolites on breast cancer and endothelial cell proliferation.

  2004cites this paper
• Cardiovascular Pharmacology of Estradiol Metabolites

  2004cites this paper
• Effect of 2-methoxyestradiol on the growth of methyl-nitroso-urea (MNU)-induced rat mammary carcinoma.

  2003cites this paper
• Primär- und Sekundärprävention kardiovaskulärer Erkrankungen durch Hormonsubstitution

  2003cites this paper
• Chemotherapeutics and Hormesis

  2003cites this paper
• Östrogenabhängige Neoplasien - welche Bedeutung haben Estradiolmetaboliten

  2003cites this paper
• Large-conductance Ca2+- activated K+ channels:physiological role and pharmacology.

  2003cites this paper
• Smoking, estradiol metabolism and hormone replacement therapy.

  2003cites this paper
• Novel 2-methoxyestradiol analogues with antitumor activity.

  2003cites this paper
• Effect of tamoxifen and 2-methoxyestradiol alone and in combination on human breast cancer cell proliferation.

  2003cites this paper
• Endogenous estradiol metabolites stimulate the in vitro proliferation of human osteoblastic cells.

  2003cites this paper
• Primär- und Sekundärprävention kardiovaskulärer Erkrankungen durch Hormonsubstitution

  2003cites this paper
• Primär- und Sekundär- prävention kardiovaskulärer Erkrankungen durch Hormonsubstitution

  2003cites this paper
• Novel 2-Methoxyestradiol Analogues with Antitumor Activity 1

  2003cites this paper
• Composition pharmaceutique comprenant des derives d'estetrol utilises dans la therapie anticancereuse

  2003cites this paper
• The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells.

  2003cites this paper
• The Maturing of Hormesis as a Credible Dose-Response Model

  2003influential citation
• Applications of hormesis in toxicology, risk assessment and chemotherapeutics.

  2002cites this paper
• 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.

  2002cites this paper
• Time- and dose-dependent differential upregulation of three genes by 17 beta-estradiol in endothelial cells.

  2002cites this paper
• Hormone und Statine - Was spricht für eine Kombination?

  2002cites this paper
• Statins and menopausal health

  2002cites this paper
• 2-Methoxyestradiol Inhibits Proliferation and Induces Apoptosis Independently of Estrogen Receptors α and β

  2002cites this paper
• Estradiol metabolism and malignant disease.

  2002influential citation
• Cardiovascular protective effects of 17beta-estradiol metabolites.

  2001cites this paper
• Invited Review: Cardiovascular protective effects of 17β-estradiol metabolites

  2001cites this paper
• Inhibition of Large-Conductance Calcium-Activated Potassium Channel by 2-Methoxyestradiol in Cultured Vascular Endothelial (HUV-EC-C) Cells

  2001cites this paper